AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Medicis Declares Cash Dividend.

Business Wire

| September 19, 2003 | COPYRIGHT 2003 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

Business Editors/Health/Medical Writers

SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Sept. 19, 2003

Medicis (NYSE:MRX) today announced that its Board of Directors declared a quarter-end cash dividend of $0.05 per issued and outstanding share of its Common Stock payable on October 31, 2003, to stockholders of record at the close of business on October 1, 2003.

Medicis is the leading independent specialty pharmaceutical company in the United States focusing primarily on the treatment of dermatological, pediatric and podiatric conditions. Medicis has leading prescription products in a number of therapeutic categories, including acne, asthma, eczema, fungal infections, hyperpigmentation, photoaging, psoriasis, rosacea, seborrheic dermatitis and skin and skin-structure infections. The Company's products have earned wide acceptance by both physicians and patients due to their clinical effectiveness, high quality and cosmetic elegance.

The Company's products include the prescription brands DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox), LUSTRA(R) (hydroquinone), LUSTRA-AF(R) (hydroquinone) with sunscreen, ALUSTRA(R) (hydroquinone) with retinol, OMNICEF(R) (cefdinir), ORAPRED(R) (prednisolone sodium phosphate), PLEXION(R) Cleanser (sodium sulfacetamide/sulfur), PLEXION TS(R) (sodium sulfacetamide/sulfur), PLEXION SCT(R) (sodium sulfacetamide/sulfur), TRIAZ(R) (benzoyl peroxide), LIDEX(R) (fluocinonide), and SYNALAR(R) (fluocinolone acetonide), the over-the-counter brand ESOTERICA(R), and BUPHENYL(R) (sodium phenylbutyrate), a prescription product indicated in the treatment of Urea Cycle Disorder. For more information about Medicis, please visit the Company's website at www.medicis.com.

Except for historical information, this press release includes "forward-looking statements" within the meaning of the Securities Litigation Reform Act. All statements included in this press release that address activities, events or developments that Medicis expects, believes or anticipates will or may occur in the future are forward-looking statements. This includes earnings estimates, future financial performance and other matters. These statements are based on certain assumptions made by Medicis based on its experience and perception of historical trends, current conditions, expected future developments and other factors it believes are appropriate ...

Related articles from newspapers, magazines, journals, and more
Medicis to Present at UBS Global Pharmaceuticals Conference.
Press release article from: Business Wire May 19, 2005 700+ words
...outstanding will have on Medicis' results of operations. Forward-looking statements represent the judgment of Medicis' management as...update any forward-looking statements. NOTE: Full prescribing...information for any Medicis prescription product...
Medicis to Present at Deutsche Bank 30th Annual Health Care Conference.
Press release article from: Business Wire April 29, 2005 700+ words
...operations. Forward-looking statements represent the judgment of Medicis' management as...release, and Medicis disclaims any...any forward-looking statements. NOTE: Full...information for any Medicis prescription product...
Medicis to Present at Thomas Weisel Partners Healthcare Tailwinds 2003...
Press release article from: Business Wire August 28, 2003 700+ words
...operations. Forward-looking statements represent the judgment of Medicis' management as...release, and Medicis disclaims any...any forward-looking statements. NOTE: Full...information for any Medicis prescription product...
Medicis to Present at 22nd Annual J.P. Morgan Healthcare Conference.
Press release article from: Business Wire January 8, 2004 700+ words
...2003. Forward-looking statements represent the judgment of Medicis' management as...release, and Medicis disclaims any...any forward-looking statements. NOTE: Full...information for any Medicis prescription product...
Medicis to Present at UBS Global Life Sciences Conference.
Press release article from: Business Wire September 23, 2004 700+ words
...operations. Forward-looking statements represent the judgment of Medicis' management as...release, and Medicis disclaims any...any forward-looking statements. NOTE: Full...information for any Medicis prescription product...
Medicis to Present at Banc of America Securities 2003 Healthcare Conference.
Press release article from: Business Wire March 24, 2003 700+ words
...operations. Forward-looking statements represent the judgment of Medicis' management as...release, and Medicis disclaims any...any forward-looking statements. NOTE: Full...information for any Medicis prescription product...
Medicis to Present at Thomas Weisel Partners Growth Forum 7.0.
Press release article from: Business Wire June 9, 2005 700+ words
...outstanding will have on Medicis' results of operations. Forward-looking statements represent the judgment of Medicis' management as...update any forward-looking statements. NOTE: Full prescribing...information for any Medicis prescription product...
Medicis to Present at Merrill Lynch 16th Annual Global Pharmaceutical,...
Press release article from: Business Wire February 7, 2005 700+ words
...operations. Forward-looking statements represent the judgment of Medicis' management as...release, and Medicis disclaims any...any forward-looking statements. NOTE: Full...information for any Medicis prescription product...
Medicis to Present at 2004 Merrill Lynch Global Pharmaceutical, Biotechnology &...
Press release article from: Business Wire February 2, 2004 700+ words
...2003. Forward-looking statements represent the judgment of Medicis' management as...release, and Medicis disclaims any...any forward-looking statements. NOTE: Full...information for any Medicis prescription product...
Medicis to Present at Thomas Weisel Partners Growth Forum 5.0.
Press release article from: Business Wire June 12, 2003 700+ words
...operations. Forward-looking statements represent the judgment of Medicis' management as...release, and Medicis disclaims any...any forward-looking statements. NOTE: Full...information for any Medicis prescription product...
For more facts and information, see all results

Source: HighBeam Research, Medicis Declares Cash Dividend.

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA